Company
Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
We’re building something special — and we’d love for you to be a part of it. Explore our current openings and see where a career at Gossamer Bio can take you.
Open roles
1
live now
New today
0
last 24 hours
Worldwide remote
0
from anywhere
Departments
1
hiring across